Retrophin, Inc. (NASDAQ:RTRX) today announced that it will report its
third quarter financial results on Thursday, November 13, 2014 after the
close of the U.S. financial markets. At 4:30 p.m. ET, Retrophin’s
management will host a conference call and webcast to discuss the
company’s financial results for the third quarter 2014 and provide a
general business update.
Conference Call Information
|
|
|
Date:
|
|
|
|
Thursday, November 13, 2014
|
|
Time:
|
|
|
|
4:30 p.m. ET
|
|
Dial-in numbers:
|
|
|
|
+1 (855) 219-9219 (U.S.) or +1 (315) 625-6891 (International)
|
|
Confirmation code:
|
|
|
|
26969110
|
|
Live webcast:
|
|
|
|
www.retrophin.com
in the “Events & Presentations” section of the “Investors” page
|
|
|
A replay of the call will be available 7:30 p.m. ET, November 13, 2014
to 11:59 p.m., November 20, 2014. The replay number is 855-859-2056
(U.S.) or 404-537-3406 (International), confirmation code 26969110.
About Retrophin
Retrophin is a pharmaceutical company focused on the development,
acquisition and commercialization of drugs for the treatment of serious,
catastrophic or rare diseases for which there are currently no viable
options for patients. The Company's approved products include Chenodal®,
Thiola® and Vecamyl®, and its pipeline includes compounds for several
catastrophic diseases, including focal segmental glomerulosclerosis
(FSGS), pantothenate kinase-associated neurodegeneration (PKAN),
schizophrenia, infantile spasms, nephrotic syndrome and others. For
additional information, please visit www.retrophin.com.
Forward-Looking Statements
This press release contains "forward-looking statements" as that term is
defined in the Private Securities Litigation Reform Act of 1995,
regarding the research, development and commercialization of
pharmaceutical products. Without limiting the foregoing, these
statements are often identified by the words "may", "might", "believes",
"thinks", "anticipates", "plans", "expects", "intends" or similar
expressions. No forward-looking statement can be guaranteed. You are
cautioned not to place undue reliance on these forward-looking
statements as there are important factors that could cause actual
results to differ materially from those in forward-looking statements,
many of which are beyond our control. The Company undertakes no
obligation to publicly update forward-looking statements, whether as a
result of new information, future events, or otherwise. Investors are
referred to the full discussion of risks and uncertainties as included
in the Company's filings with the Securities and Exchange Commission.
Copyright Business Wire 2014